These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 14508798)

  • 1. Infliximab for steroid-refractory acute GVHD: a case series.
    Jacobsohn DA; Hallick J; Anders V; McMillan S; Morris L; Vogelsang GB
    Am J Hematol; 2003 Oct; 74(2):119-24. PubMed ID: 14508798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infliximab treatment for steroid-refractory acute graft-versus-host disease.
    Patriarca F; Sperotto A; Damiani D; Morreale G; Bonifazi F; Olivieri A; Ciceri F; Milone G; Cesaro S; Bandini G; Dini G; Corradini P; Fanin R
    Haematologica; 2004 Nov; 89(11):1352-9. PubMed ID: 15531458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infliximab for GVHD therapy in children.
    Sleight BS; Chan KW; Braun TM; Serrano A; Gilman AL
    Bone Marrow Transplant; 2007 Sep; 40(5):473-80. PubMed ID: 17618323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of severe steroid refractory acute graft-versus-host disease with infliximab, a chimeric human/mouse antiTNFalpha antibody.
    Kobbe G; Schneider P; Rohr U; Fenk R; Neumann F; Aivado M; Dietze L; Kronenwett R; Hünerlitürkoglu A; Haas R
    Bone Marrow Transplant; 2001 Jul; 28(1):47-9. PubMed ID: 11498743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infliximab treatment for steroid-refractory acute graft-versus-host disease after orthotopic liver transplantation: a case report.
    Piton G; Larosa F; Minello A; Becker MC; Mantion G; Aubin F; Deconinck E; Hillon P; Di Martino V
    Liver Transpl; 2009 Jul; 15(7):682-5. PubMed ID: 19562700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term follow-up of patients treated with daclizumab for steroid-refractory acute graft-vs-host disease.
    Perales MA; Ishill N; Lomazow WA; Weinstock DM; Papadopoulos EB; Dastigir H; Chiu M; Boulad F; Castro-Malaspina HR; Heller G; Jakubowski AA; O'Reilly RJ; Small TN; Young JW; Kernan NA
    Bone Marrow Transplant; 2007 Sep; 40(5):481-6. PubMed ID: 17618322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crypt loss is a marker of clinical severity of acute gastrointestinal graft-versus-host disease.
    Melson J; Jakate S; Fung H; Arai S; Keshavarzian A
    Am J Hematol; 2007 Oct; 82(10):881-6. PubMed ID: 17570511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant human soluble tumor necrosis factor receptor fusion protein as treatment for steroid refractory graft-versus-host disease following allogeneic hematopoietic stem cell transplantation.
    Busca A; Locatelli F; Marmont F; Ceretto C; Falda M
    Am J Hematol; 2007 Jan; 82(1):45-52. PubMed ID: 16937391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Daclizumab for children with corticosteroid refractory graft-versus-host disease.
    Teachey DT; Bickert B; Bunin N
    Bone Marrow Transplant; 2006 Jan; 37(1):95-9. PubMed ID: 16247417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracorporeal photopheresis for acute and chronic graft-versus-host disease: does it work?
    Couriel D; Hosing C; Saliba R; Shpall EJ; Andelini P; Popat U; Donato M; Champlin R
    Biol Blood Marrow Transplant; 2006 Jan; 12(1 Suppl 2):37-40. PubMed ID: 16399600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infliximab for steroid refractory or dependent gastrointestinal acute graft-versus-host disease in children after allogeneic hematopoietic stem cell transplantation.
    Yang J; Cheuk DK; Ha SY; Chiang AK; Lee TL; Ho MH; Chan GC
    Pediatr Transplant; 2012 Nov; 16(7):771-8. PubMed ID: 22905718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastrointestinal toxicity from the preparative regimen is associated with an increased risk of graft-versus-host disease.
    Goldberg J; Jacobsohn DA; Zahurak ML; Vogelsang GB
    Biol Blood Marrow Transplant; 2005 Feb; 11(2):101-7. PubMed ID: 15682070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved survival and preserved antiviral responses after combination therapy with daclizumab and infliximab in steroid-refractory graft-versus-host disease.
    Rao K; Rao A; Karlsson H; Jagani M; Veys P; Amrolia PJ
    J Pediatr Hematol Oncol; 2009 Jun; 31(6):456-61. PubMed ID: 19648797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical utility of rituximab in chronic graft-versus-host disease.
    Bates JS; Engemann AM; Hammond JM
    Ann Pharmacother; 2009 Feb; 43(2):316-21. PubMed ID: 19193571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Salvage treatment with infliximab of steroid-resistant graft-versus-host disease in allogeneic transplanted patients].
    Motlló C; Ferrà C; López L; Morgades M; Batlle M; Ribera JM
    Med Clin (Barc); 2011 Jun; 137(3):115-8. PubMed ID: 21543091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracorporeal photopheresis for the treatment of steroid refractory acute GVHD.
    Perfetti P; Carlier P; Strada P; Gualandi F; Occhini D; Van Lint MT; Ibatici A; Lamparelli T; Bruno B; Raiola AM; Dominietto A; Di Grazia C; Bregante S; Zia S; Ferrari GM; Stura P; Pogliani E; Bacigalupo A
    Bone Marrow Transplant; 2008 Nov; 42(9):609-17. PubMed ID: 18660840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of acute and chronic graft-versus-host disease on normal and malignant B-lymphoid precursors after allogeneic stem cell transplantation for B-lineage acute lymphoblastic leukemia.
    Sánchez-García J; Serrano J; Gómez P; Martínez F; Martín C; Román-Gómez J; Rodríguez A; Herrera C; García JM; Alvarez MA; Torres A
    Haematologica; 2006 Mar; 91(3):340-7. PubMed ID: 16531257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of extracorporeal photoimmunotherapy (ECP) on serum TNF-a level in chronic graft versus host disease (GvHD).
    Ayyildiz E; Arslan O; Topçuoğlu P; Arat M; Dalva K; Soydan EA; Tol M; Ilhan O
    Transfus Apher Sci; 2007 Feb; 36(1):79-85. PubMed ID: 17234454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of severe steroid-refractory graft-versus-host disease with IL-2R alpha chain (CD25) monoclonal antibody].
    Lu J; Xu LP; Huang XJ; Chen H; Zhang YC; Ren HY; Guo NL; Lu DP
    Zhonghua Yi Xue Za Zhi; 2003 Feb; 83(3):216-9. PubMed ID: 12812665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current and novel therapies in acute GVHD.
    Ho VT; Cutler C
    Best Pract Res Clin Haematol; 2008 Jun; 21(2):223-37. PubMed ID: 18503988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.